EPCAM and hepatocellular carcinoma: We also reported a negative correlation between miR-122 and both CD133 and EpCAM stem cell markers in an HCC patient cohort, and demonstrated their negative regulation by miR-122 in HCC cell lines, confirming the active role for miR-122 in stem cell regulation in liver cancer [71].